Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Definitive Healthcare (DH) Other Operating Expenses (2020 - 2025)

Definitive Healthcare's Other Operating Expenses history spans 6 years, with the latest figure at $48.8 million for Q4 2025.

  • For Q4 2025, Other Operating Expenses fell 61.51% year-over-year to $48.8 million; the TTM value through Dec 2025 reached $313.4 million, down 61.32%, while the annual FY2025 figure was $313.5 million, 61.31% down from the prior year.
  • Other Operating Expenses reached $48.8 million in Q4 2025 per DH's latest filing, up from $29.5 million in the prior quarter.
  • In the past five years, Other Operating Expenses ranged from a high of $394.6 million in Q2 2024 to a low of -$248.9 million in Q3 2023.
  • Average Other Operating Expenses over 5 years is $36.7 million, with a median of -$10.0 million recorded in 2021.
  • Peak YoY movement for Other Operating Expenses: crashed 1642.42% in 2023, then soared 3075.61% in 2024.
  • A 5-year view of Other Operating Expenses shows it stood at -$14.4 million in 2021, then soared by 123.71% to $3.4 million in 2022, then tumbled by 492.08% to -$13.4 million in 2023, then skyrocketed by 1049.48% to $126.9 million in 2024, then plummeted by 61.51% to $48.8 million in 2025.
  • Per Business Quant, the three most recent readings for DH's Other Operating Expenses are $48.8 million (Q4 2025), $29.5 million (Q3 2025), and $29.5 million (Q2 2025).